CCT4 and glioblastoma: They also observed that the YB-1/CCT4/mLST8/mTOR axis promoted GBM growth in vivo in a mouse xenograft model, whereas the administration of RNA decoys specifically targeting YB-1 repressed tumor growth and increased survival [114].